
Browsing restrictions can be lifted for a fee.
Ma Kuang Healthcare Holding Limited, an investment holding company, provides medical services in Taiwan and internationally. The company offers community medical services, Chinese medical services, Chinese medicines, medical management training courses, educational support services, etc. It also provides medical treatment, and overseas student homestay and guardianship services; management consultant services; Chinese medicine beauty services; consulting services, such as corporate management, computer technology, industry information, and marketing; and e-commerce sales services. In addition, the company operates clinics, educational institutions, community medicine clinics, and traditional Chinese medicine clinics. Further, it is involved in sale of dietary supplement, and pharmaceutical and medical goods in stores; restaurant business; and lease and other services. The company was incorporated in 2009 and is based in Kaohsiung, Taiwan.
4139
馬光-KY
-0.64%
(-0.01)
The most recent financial report for 馬光-KY (4139) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 4139's short-term business performance and financial health. For the latest updates on 4139's earnings releases, visit this page regularly.
According to the latest financial report, 馬光-KY (4139) reported an Operating Profit of -7.8M with an Operating Margin of -2.96% this period, representing a decline of 314.49% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, 馬光-KY (4139) announced revenue of 263.6M, with a Year-Over-Year growth rate of -10.03%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, 馬光-KY (4139) held Total Cash and Cash Equivalents of 90.91M, accounting for 0.07 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, 馬光-KY (4139) did not achieve the “three margins increasing” benchmark, with a gross margin of 10.34%%, operating margin of -2.96%%, and net margin of -4.88%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 4139's profit trajectory and future growth potential.
According to the past four quarterly reports, 馬光-KY (4139)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.2. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
馬光-KY (4139)'s Free Cash Flow (FCF) for the period is 21.32M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 73.88% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.